by Catalin | Sep 7, 2026 | 2026 vol. 4 Issue 3
Nitric Oxide, Tumor Necrosis Factor-α, and Lipid Peroxidation as Biomarkers of Endothelial Injury in Sickle Cell Disease Fidelis Ohiremen OYAKHIRE, Grace Oluwapelumi BONIDEFAYE, Kikachukwu Favour OSAHOR, Juliana Edusola OLANIYAN, Tena Gloria LEMON, Jennifer...
by Catalin | Sep 7, 2026 | 2026 vol. 4 Issue 3
When the Eyes Speak: A Multisystem Challenge with CNS and Orbital Spread Light Chain Myeloma Nasim SALIMIAGHDAM, Usha NIRANJAN Introduction. Multiple myeloma (MM) is a type of cancer that affects plasma cells and makes up about 10% of blood cancer. It’s characterized...
by Catalin | Sep 7, 2026 | 2026 vol. 4 Issue 3
Unmasking VEXAS Syndrome: A Diagnostic Dilemma Kanupriya BECTOR, Ankur PUNIA, Shweta BANSAL, Sapna YADAV, Priyanka CHOUDHARY, Suchita VERMA, Omkar Kalidasrao CHOUDHARI, Ajay YADAV, Satyajeet SONI, Naveen GUPTA, Hemant MALHOTRA Background: VEXAS syndrome is caused by a...
by Catalin | Sep 7, 2026 | 2026 vol. 4 Issue 3
TP53-Mutated Myelodysplastic Syndrome with Bone Marrow Fibrosis in a Young Adult: A Rare Diagnostic and Therapeutic Challenge Mayank PANDEY, Tuphan Kanti DOLAI, Kaustav GHOSH Introduction: Myelodysplastic syndrome with fibrosis (MDS-F) is a rare and biologically...
by Catalin | Sep 7, 2026 | 2026 vol. 4 Issue 3
Kimura Disease – Not Every Lymphadenopathy is Malignant Vaishali SHARAI, Shweta BANSAL, Gaurav OJHA, Manish VIJAYVARGIYA, Vijeta NIRANJAN, Omkar Kalidasrao CHOUDHARI, Priyanka SONI, Naveen GUPTA, Hemant MALHOTRA Introduction. Any obvious lymphadenopathy should be...
